These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 18370923)

  • 21. [Mechanisms of action of intravenous immunoglobulins].
    Kaveri SV
    Bull Acad Natl Med; 2012 Jan; 196(1):39-47; discussion 47-8. PubMed ID: 23259331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
    Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
    Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
    Michael D; Grando SA
    Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel roles for the IgG Fc glycan.
    Anthony RM; Wermeling F; Ravetch JV
    Ann N Y Acad Sci; 2012 Apr; 1253():170-80. PubMed ID: 22288459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg.
    Masson PL
    J Autoimmun; 1993 Dec; 6(6):683-9. PubMed ID: 8155250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of anti-inflammatory activity of intravenous immunoglobulin via inhibitory Fcgamma receptors.
    Maródi L
    Pediatr Res; 2001 Nov; 50(5):551. PubMed ID: 11641444
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of action of intravenous immunoglobulin (IVIG).
    Kazatchkine MD; Bellon B; Kaveri SV
    Mult Scler; 2000 Oct; 6 Suppl 2():S24-6; discussion S33. PubMed ID: 11188775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of immune regulation by IVIG.
    Ballow M
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high Fc gammaRIIB to Fc gammaRIII expression ratio on macrophages.
    Konrad S; Baumann U; Schmidt RE; Gessner JE
    Br J Haematol; 2006 Aug; 134(3):345-7. PubMed ID: 16848778
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases.
    Norris PAA; Kaur G; Lazarus AH
    Curr Opin Hematol; 2020 Nov; 27(6):392-398. PubMed ID: 32868670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
    Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
    Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoglobulins and physiopathology: actual indications].
    Mouthon L; Guilpain P
    Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.